
Smiths Detection on Tuesday said it has completed its acquisition of PathSensors, a developer of biological detection technology used in defense, food safety and emerging disease applications. Terms of the deal were not disclosed. Smiths Detection is part of Britain’s Smiths Group. PathSensors, which is based in Baltimore, has bio-detection technology for detecting deadly pathogens. The company also says it has technology for aerosol detection of COVID-19. “We are pleased to be able to complete this acquisition, which we view…